We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Synectics Plc | LSE:SNX | London | Ordinary Share | GB0007156838 | ORD 20P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-2.00 | -0.60% | 333.00 | 330.00 | 336.00 | 335.00 | 327.00 | 335.00 | 56,838 | 15:34:47 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Elec Apparatus & Equip-whsl | 49.13M | 2.16M | 0.1281 | 26.00 | 56.58M |
Date | Subject | Author | Discuss |
---|---|---|---|
20/8/2007 09:04 | Hi "Colin". get yer bog brush ready. | cat | |
09/8/2007 20:11 | Flush this into the vortex Colin | smashingguy | |
31/7/2007 08:04 | getting a bit smelly CNP chicken came home to roost today the stock market is not the place for a clinical research company - the market cannot cope with trial delays. | cat | |
10/7/2007 12:23 | its a pile of plop | cat | |
04/5/2007 02:21 | Yep, it would be great to see this sub 50p - providing the board are not telling porkies and the contracts are only overlapping end of year, then next results should be very strong. | papalpower | |
03/5/2007 15:49 | One to watch-going down | volsung | |
24/2/2007 11:51 | you are correct on that papalpower, but one has to say it must be truthful and it is slippage, but you will have to wait a long time to find out as it will not be this years results but the following year so do you want to tie an investment for a couple of years to find out, me i am out of here and will come back if there is no more profits warnings or further slippage, when in doubt get out, that is what i am doing, best of luck to those who stayed in and i hope you make a few bob, same to those who are getting in after my departure. | bigman | |
22/2/2007 11:16 | Depends on how truthful the profit warning was.......is its correct and its purely slippage into next financial year, then on a forward basis next year will be better than original forecasts, at the expense of this year. | papalpower | |
22/2/2007 11:13 | I dont think so re the bottom this came to market placed at 66p with no doubt a brokers forecast, issue a profit warning so they cannot possibly be worth more than 66p indeed one could say that a profit warning should half a share price ie in the 30p s simple logic what would they have been priced at on float with the current situation....i would suggest no where near 65p.... 35p more like.. IMHO | bigman | |
21/2/2007 13:57 | Target: 26p. Cheers Lee | leytonorient | |
19/2/2007 15:11 | And again..... Worth a second look sub 50p. | 2lb | |
15/2/2007 22:23 | Down again today. | leytonorient | |
12/2/2007 23:05 | Former Chief Operating Officer resigned in Feb I presume - why? | leytonorient | |
06/2/2007 12:41 | cat:. Thanks for trying. Athough I have been associated with drug companies in the past the technology and theory hare is a bit byond me. Not too good an indicator that phone not answered. | pugugly | |
06/2/2007 10:48 | pugugly - looks interesting but tried to ring the co to find out more and simply got an answering machine. | cat | |
06/2/2007 10:33 | director buying today pathetic attempt to shore stock price up. the company model is wrong and will likely fail. big pharma want traditional full service CROs. this co should never have come to market. Institutional investors could have been stung and will be lucky to get any of their money back pugugly i'll have a look. | cat | |
01/2/2007 22:00 | never heard of this company till I read a feature article in today thursday's FT about Ian Smith. after the fall seems worth a look | cerrito | |
01/2/2007 09:28 | no bounce, just sinkinging still/ | leytonorient | |
28/1/2007 10:55 | Cash is prob | leytonorient | |
26/1/2007 19:15 | Very unsettling news The market doesn't like this. Unfortunately I feel we have significantly further to fall. It is particularly annoying after the recent encouraging results - shakes your confidence in the management. Hopeful of support at 50p | oharebj | |
26/1/2007 11:58 | Cat:. Right as usual in your specialist area - Your post 17. In this area do you have any knowledge of Epistem Ltd? - A private company that may be looking for funds. - If so what do you think of the technology - ? Web site Any thoughts would be appreciated. | pugugly | |
26/1/2007 11:11 | I did look at the these but any business running a low cost model could always hit the buffers if the barriers to entry are also low. Obviously not good to have a profits warning so soon after their December update, but with the market cap equal to their order book it makes it interesting to watch. Thats all I'll do for now though. Not the most lively of BB's. | dr biotech |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions